PCLA:NASDAQPicoCELA Inc. Analysis
Data as of 2026-05-19 - not real-time
$1.45
Latest Price
8/10Risk
Risk Level: High
Executive Summary
PicoCELA Inc. trades at $1.45, barely above its 20‑day support of $1.35, while the 14‑day RSI sits at 28, indicating oversold conditions. Technical indicators – a bearish MACD and a down‑trend direction – suggest further downside pressure, yet volume is increasing, hinting at renewed market interest. Fundamentally, the company reports a 42% revenue decline, negative operating and profit margins, and an EBITDA loss exceeding $570 M, underscoring severe earnings weakness. However, the stock’s price‑to‑book (0.56) and price‑to‑sales (0.03) ratios are dramatically low, reflecting a market‑price discount relative to its balance‑sheet assets. Cash on hand ($535 M) exceeds total debt ($282 M), providing a cushion, but free cash flow remains deeply negative, and the debt‑to‑equity ratio is high at ~60. Volatility is extreme at 82% over 30 days, and beta exceeds 2, indicating high sensitivity to market moves. Recent news touts a new proprietary wireless mesh technology unveiled at Wi‑Fi World Congress, which could be a catalyst if commercial adoption materializes, but the claim of “one of the best Japanese stocks to buy” lacks independent verification. Overall, the stock appears heavily discounted but burdened by deteriorating fundamentals, high volatility, and liquidity constraints, making any upside highly speculative.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish technical momentum (MACD, trend direction)
- Negative earnings and cash flow
- Low trading volume and high liquidity risk
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside from new mesh technology launch
- Strong cash position relative to debt
- Continued earnings deficits and high volatility
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Sustained revenue decline and profit losses
- Uncertain path to profitability despite cash reserves
- Elevated beta and extreme price volatility
Key Metrics & Analysis
Financial Health
Revenue Growth-42.30%
Profit Margin-114.98%
ROE-151.88%
ROA-32.38%
Debt/Equity59.91
P/B Ratio0.6
Op. Cash Flow$-544019968
Free Cash Flow$-412667616
Industry P/E17.2
Technical Analysis
TrendBearish
RSI28.2
Support$1.35
Resistance$2.35
MA 20$1.86
MA 50$2.13
MA 200$8.02
MACDBearish
VolumeIncreasing
Fear & Greed Index89.32
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta2.22
Volatility82.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.